ISTA Pharma Committee Seeking Peer Review on New Guideline

The committee is putting out a call for comments on its Thermal Packaging System Ambient Temperature Profile (ATP) Best Practice Guideline.

Ista Logo

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The ISTA Pharma Committee is seeking industry peer review on its latest best practice guideline “ISTA PCG-04 Thermal Packaging System Ambient Temperature Profile (ATP) Best Practice Guideline.”

The committee’s goal was to establish an aligned industry best practice for the selection, development, and comparison of ATPs for use in the thermal qualification testing of thermal packaging to transport temperature-sensitive medicinal products. This collaborative effort between life science companies and solution providers resulted in a mutually beneficial and harmonized best practice guideline to aid the industry in comparing, investigating, and implementing agile compliant solutions.

To provide comments, click here. ISTA is seeking feedback on specific items that organizations cannot comply with (and why), any missing details, and/or content that needs further clarification. It is not looking for feedback around grammar and formatting. The deadline for comments is Friday, February 17, 2023.

For any questions, email ISTA at [email protected] or call 517.333.3437.


List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?